Earnings Call · Q3 FY2021·2021-11-09

Q3 21EPS -33.33%·Rev n/aQ2 21EPS -100.00%*·Rev n/aQ1 21EPS -2.63%·Rev n/aQ4 20EPS -27.87%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal Officer

Carl Hansen — Chief Executive Officer

Andrew Booth — Unknown - likely senior management or investor relations based on context

−4.0%1d on move date−3.7% vs SPY3d−1.8%5d+6.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access